An intratumoral controlled release formulation of clusterin antisense oligonucleotide and paclitaxel or docetaxel for treatment of prostate tumors
Surgical procedures performed on blood vessels may cause irritation of the vessel wall. This irritation sets off a series of complicated steps, which results in a growth of the vessel wall towards the center of the blood vessel, and a narrowing of the amount of space for the blood to flow through...
Main Author: | Springate, Christopher Michael Kevin |
---|---|
Language: | English |
Published: |
2009
|
Online Access: | http://hdl.handle.net/2429/9258 |
Similar Items
-
An intratumoral controlled release formulation of clusterin antisense oligonucleotide and paclitaxel or docetaxel for treatment of prostate tumors
by: Springate, Christopher Michael Kevin
Published: (2009) -
An intratumoral controlled release formulation of clusterin antisense oligonucleotide and paclitaxel or docetaxel for treatment of prostate tumors
by: Springate, Christopher Michael Kevin
Published: (2011) -
Cytotoxic effects of Clusterin antisense oligonucleotides and Docetaxel on two prostate cancer cell lines
by: N. Bakhtiari, et al.
Published: (2015-06-01) -
The synergy of gemcitabine with clusterin antisense oligonucleotides in the treatment of bladder cancer
by: Glackin, A. J.
Published: (2005) -
Chemosensitization of Human Renal Cell Cancer Using Antisense Oligonucleotides Targeting the Antiapoptotic Gene Clusterin
by: Tobias Zellweger, et al.
Published: (2001-01-01)